Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond

Sandro V Porceddu; Bryan H Burmeister; Rodney J Hicks

doi:10.1016/j.hoc.2008.08.009

Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond

Hematol Oncol Clin North Am. 2008 Dec;22(6):1221-38, ix-x. doi: 10.1016/j.hoc.2008.08.009.

Authors

Sandro V Porceddu¹, Bryan H Burmeister, Rodney J Hicks

Affiliation

¹ Division of Cancer Services, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Queensland, Australia 4102. sandro_porceddu@health.qld.gov.au

PMID: 19010270
DOI: 10.1016/j.hoc.2008.08.009

Abstract

Positron emission tomography (PET) has emerged as an integral diagnostic tool in the management of head and neck squamous cell carcinoma (HNSCC). This article reviews the usefulness and ongoing dilemmas of fluorine-18 fluorodeoxyglucose (18-F FDG) PET and FDG PET/CT in HNSCC. In addition, it examines the potential role of novel markers and biologic characterization of disease, which in the future may assist in targeted therapeutic strategies.

Publication types

Review

MeSH terms

Fluorodeoxyglucose F18 / administration & dosage*
Head and Neck Neoplasms / diagnostic imaging*
Head and Neck Neoplasms / radiotherapy
Humans
Monitoring, Physiologic / methods*
Positron-Emission Tomography / methods*
Radiography
Radiopharmaceuticals / administration & dosage*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18